PAPER Feldman EL, Boulis NM, Hur J, Johe K, Rutkove SB, Federici T, Polak M, Bordeau J, Sakowski SA, Glass JD
SEARCH RESULTS
331254 RESULTS
PAPER Majmudar S, Wu J, Paganoni S
Rehabilitation in amyotrophic lateral sclerosis: why it matters.
Muscle Nerve. 2014 Jul;50(1):4-13. Epub 2014 May 17 PubMed: 24510737PAPER Valavanis A, Schwarz U, Baumann CR, Weller M, Linnebank M
Amyotrophic lateral sclerosis after embolization of cerebral arterioveneous malformations.
J Neurol. 2014 Apr;261(4):732-7. Epub 2014 Feb 8 PubMed: 24509642PAPER Qiu H, Lee S, Shang Y, Wang WY, Au KF, Kamiya S, Barmada SJ, Finkbeiner S, Lui H, Carlton CE, Tang AA, Oldham MC, Wang H, Shorter J, Filiano AJ, Roberson ED, Tourtellotte WG, Chen B, Tsai LH, Huang EJ
ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects.
J Clin Invest. 2014 Mar 3;124(3):981-99. Epub 2014 Feb 10 PubMed: 24509083PAPER Gascon E, Gao FB
The emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disorders.
J Neurogenet. 2014 Mar-Jun;28(1-2):30-40. Epub 2014 Feb 10 PubMed: 24506814PAPER
Alzheimer's Association update.
Alzheimers Dement. 2014 Jan;10(1):132-3. PubMed: 24511628PAPER Robin NC, Agoston Z, Biechele TL, James RG, Berndt JD, Moon RT
Simvastatin Promotes Adult Hippocampal Neurogenesis by Enhancing Wnt/β-Catenin Signaling.
Stem Cell Reports. 2014 Jan 14;2(1):9-17. Epub 2013 Dec 26 PubMed: 24511465PAPER Canudas J, Insua D, Sarasa L, González-Martínez A, Suárez ML, Santamarina G, Pesini P, Sarasa M
Neprilysin is poorly expressed in the prefrontal cortex of aged dogs with cognitive dysfunction syndrome.
Int J Alzheimers Dis. 2014;2014:483281. Epub 2014 Jan 6 PubMed: 24511411PAPER Foster DJ, Choi DL, Conn PJ, Rook JM
Activation of M1 and M4 muscarinic receptors as potential treatments for Alzheimer's disease and schizophrenia.
Neuropsychiatr Dis Treat. 2014;10:183-91. Epub 2014 Jan 28 PubMed: 24511233PAPER Ihara M, Taguchi A, Maki T, Washida K, Tomimoto H
A mouse model of chronic cerebral hypoperfusion characterizing features of vascular cognitive impairment.
Methods Mol Biol. 2014;1135:95-102. PubMed: 24510857PAPER Ithapu V, Singh V, Lindner C, Austin BP, Hinrichs C, Carlsson CM, Bendlin BB, Johnson SC
Extracting and summarizing white matter hyperintensities using supervised segmentation methods in Alzheimer's disease risk and aging studies.
Hum Brain Mapp. 2014 Aug;35(8):4219-35. Epub 2014 Feb 7 PubMed: 24510744PAPER Mahoney CJ, Ridgway GR, Malone IB, Downey LE, Beck J, Kinnunen KM, Schmitz N, Golden HL, Rohrer JD, Schott JM, Rossor MN, Ourselin S, Mead S, Fox NC, Warren JD
Profiles of white matter tract pathology in frontotemporal dementia.
Hum Brain Mapp. 2014 Aug;35(8):4163-79. Epub 2014 Feb 7 PubMed: 24510641PAPER
Upcoming meetings related to Alzheimer's disease.
J Alzheimers Dis. 2014 Jan 1;39(3) PubMed: 24509628PAPER Mizoi M, Yoshida M, Saiki R, Waragai M, Uemura K, Akatsu H, Kashiwagi K, Igarashi K
Distinction between mild cognitive impairment and Alzheimer's disease by CSF amyloid β40 and β42, and protein-conjugated acrolein.
Clin Chim Acta. 2014 Mar 20;430:150-5. Epub 2014 Feb 6 PubMed: 24508996PAPER Bennett DA, Yu L, De Jager PL
Building a pipeline to discover and validate novel therapeutic targets and lead compounds for Alzheimer's disease.
Biochem Pharmacol. 2014 Apr 15;88(4):617-30. Epub 2014 Feb 6 PubMed: 24508835Current Filters
No filters selected